| CAR T cells in solid tumors: challenges and opportunities F Marofi, R Motavalli, VA Safonov, L Thangavelu, AV Yumashev, ... Stem cell research & therapy 12 (1), 1-16, 2021 | 291 | 2021 |
| Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders A Markov, L Thangavelu, S Aravindhan, AO Zekiy, M Jarahian, ... Stem cell research & therapy 12 (1), 1-30, 2021 | 256 | 2021 |
| A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine S Moghadasi, M Elveny, HS Rahman, W Suksatan, AT Jalil, ... Journal of translational medicine 19 (1), 1-21, 2021 | 198 | 2021 |
| CAR‐NK cell in cancer immunotherapy; A promising frontier F Marofi, OF Abdul‐Rasheed, HS Rahman, HS Budi, AT Jalil, ... Cancer Science 112 (9), 3427-3436, 2021 | 158 | 2021 |
| Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol P Nakhaei, R Margiana, DO Bokov, WK Abdelbasset, ... Frontiers in Bioengineering and Biotechnology, 748, 2021 | 150 | 2021 |
| Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients F Marofi, HS Rahman, ZMJ Al-Obaidi, AT Jalil, WK Abdelbasset, ... Stem Cell Research & Therapy 12 (1), 1-23, 2021 | 144 | 2021 |
| Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell-based therapy R Azizi, L Aghebati-Maleki, M Nouri, F Marofi, S Negargar, M Yousefi Biomedicine & Pharmacotherapy 102, 333-343, 2018 | 138 | 2018 |
| CTLA-4: From mechanism to autoimmune therapy A Hosseini, T Gharibi, F Marofi, Z Babaloo, B Baradaran International immunopharmacology 80, 106221, 2020 | 108 | 2020 |
| Mesenchymal stromal/stem cells: a new era in the cell-based targeted gene therapy of cancer F Marofi, G Vahedi, A Biglari, A Esmaeilzadeh, SS Athari Frontiers in immunology 8, 1770, 2017 | 102 | 2017 |
| Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial S Dolati, L Aghebati‐Maleki, M Ahmadi, F Marofi, Z Babaloo, H Ayramloo, ... Journal of cellular physiology 233 (7), 5222-5230, 2018 | 75 | 2018 |
| Targeting STAT3 in cancer and autoimmune diseases T Gharibi, Z Babaloo, A Hosseini, M Abdollahpour-Alitappeh, V Hashemi, ... European journal of pharmacology 878, 173107, 2020 | 71 | 2020 |
| Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators S Dolati, M Ahmadi, L Aghebti-Maleki, A Nikmaram, F Marofi, R Rikhtegar, ... Pharmacological reports 70, 1158-1167, 2018 | 68 | 2018 |
| Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities A Hassanzadeh, HS Rahman, A Markov, JJ Endjun, AO Zekiy, ... Stem cell research & therapy 12 (1), 1-22, 2021 | 67 | 2021 |
| Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases A Hosseini, T Gharibi, F Marofi, M Javadian, Z Babaloo, B Baradaran Journal of Cellular Physiology 235 (9), 5903-5924, 2020 | 62 | 2020 |
| A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies E Razeghian, MKM Nasution, HS Rahman, ZR Gardanova, ... Stem Cell Research & Therapy 12 (1), 1-17, 2021 | 57 | 2021 |
| CAR-NK cell: a new paradigm in tumor immunotherapy F Marofi, AS Al-Awad, H Sulaiman Rahman, A Markov, WK Abdelbasset, ... Frontiers in oncology, 2078, 2021 | 55 | 2021 |
| T cell subsets in peripheral blood of women with recurrent implantation failure M Ghaebi, S Abdolmohammadi-Vahid, M Ahmadi, S Eghbal-Fard, ... Journal of reproductive immunology 131, 21-29, 2019 | 50 | 2019 |
| Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis S Dolati, F Marofi, Z Babaloo, L Aghebati-Maleki, L Roshangar, M Ahmadi, ... Biomedicine & Pharmacotherapy 104, 280-290, 2018 | 48 | 2018 |
| Natural killer cell–based immunotherapy: From transplantation toward targeting cancer stem cells H Dianat‐Moghadam, M Rokni, F Marofi, Y Panahi, M Yousefi Journal of cellular physiology 234 (1), 259-273, 2019 | 46 | 2019 |
| MicroRNAs and signaling networks involved in epithelial–mesenchymal transition MH Musavi Shenas, S Eghbal‐Fard, V Mehrisofiani, N Abd Yazdani, ... Journal of cellular physiology 234 (5), 5775-5785, 2019 | 37 | 2019 |
Shomali,NavidPhD in Medical Immunology, Tabriz University of Medical Sciences, Tabriz, Iran在 tbzmed.ac.ir 的电子邮件经过验证
